Suki Raised $90 Million in Series E Funding

The healthcare technology company plans to use the capital to scale its AI platform and expand its agentic workflow capabilities.

Updated on Oct. 12, 2026 in Healthcare

Suki Raised $90 Million in Series E Funding

Live Poll

Do you trust that AI tools in medical offices will improve your interactions with your doctor?

Suki has secured $90 million in a Series E funding round to further develop its ambient clinical intelligence technology. This investment follows a $70 million Series D round completed in October 2024.

Why it matters

The company intends to use the capital to enhance its platform with agentic capabilities, specifically targeting automated tasks such as referrals and scheduling to improve clinical workflows. The funding underscores the rapid growth of AI-driven tools aimed at reducing administrative burdens in healthcare.

Suki currently supports over 450 healthcare organizations and maintains 30 partnerships for its AI licensing technology. The company reports that its revenue doubled in 2025 and is on track to double again in 2026.

The players

Suki

This is a healthcare technology company that specializes in AI-powered ambient clinical intelligence to automate administrative tasks for medical professionals.

Zoom Ventures

This is the corporate venture arm of the video communications company that participated as an investor in Suki's latest funding round.

The details

Founded in 2017, the platform automates clinical note-taking, revenue cycle management, and operational workflows for health providers. The company also licenses its AI technology to other health-tech firms to assist in building their own specialized medical tools.

Suki was founded in 2017.
The company raised $70 million in Series D funding in October 2024.
Suki reported that its revenue doubled in 2025.
The $90 million Series E funding was announced on October 12, 2026.

Market Landscape

Suki's expansion of agentic capabilities represents a shift toward more autonomous healthcare workflows, moving beyond simple clinical documentation. This positions the company to compete directly with other health-tech innovators racing to automate medical administrative tasks.

Patients and healthcare providers may see increased efficiency at their local clinics as Suki deploys more automated scheduling and referral features. These updates aim to reduce the time doctors spend on paperwork, potentially allowing for more focused patient interactions.

The takeaway

The continued influx of capital into medical AI suggests that automated administrative solutions will become increasingly standard in the U.S. health system. Providers looking for relief from burnout may find these evolving agentic tools increasingly common in their electronic health records.